NORDIC BIOTECH K/S: Financial statements 2014
CVR: 26290724
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -44,000 and a net result of DKK 2,030,926,000 compared with DKK 302,522,000 the year before. Equity in the 2014 report amounted to DKK 3,048,239,000. The solvency ratio was 100%.
- Gross Profit
- DKK -44,000
- Profit/Loss
- DKK 2,030,926,000
- Equity
- DKK 3,048,239,000
- Total Assets
- DKK 3,048,364,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -44K | 2B | 3B | - |
| 2013 | - | -2.8M | 302.5M | 1B | - |
| 2012 | - | - | 571.2M | 723.8M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of NORDIC BIOTECH K/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH K/S.
NORDIC BIOTECH K/S has published its annual report for 2013. Gross profit came to DKK -2,836,000, and the net result was DKK 302,522,000.
About NORDIC BIOTECH K/S
NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.